Association of apolipoprotein E4 with sporadic Alzheimer's disease is more pronounced in early onset type

Neurosci Lett. 1994 Jul 4;175(1-2):74-6. doi: 10.1016/0304-3940(94)91081-2.

Abstract

Apolipoprotein E genotypes in 88 unrelated Japanese patients with NINCDS-ADRDA sporadic Alzheimer's disease (AD) were examined and compared with those of 93 healthy controls. Frequency of epsilon 4 allele was increased in patients with AD (31%) compared with controls (10%), as was reported previously. Individuals homozygous or heterozygous for the allele epsilon 4 had a 5.9-fold increased risk of AD. This tendency was more pronounced in early onset sporadic (= non-familial) type than late onset type. The relative risk was also greater for early onset type (RR = 11.7; 95% CI, 4.9-28.3) than late onset type (RR = 4.3; 95% CI, 2.1-8.8). Moreover, patients with homozygote for the allele epsilon 4 had a 14.7-fold increased risk of early onset sporadic AD (P < 0.005, chi 2 = 9.0, df = 1, 95% CI, 2.5-85.1). Our findings indicated that association of apolipoprotein epsilon 4 with sporadic Alzheimer's disease is more pronounced in early onset type than in late onset type.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Alleles*
  • Alzheimer Disease / genetics*
  • Alzheimer Disease / physiopathology
  • Apolipoprotein E4
  • Apolipoproteins E / genetics*
  • Female
  • Genotype
  • Heterozygote
  • Homozygote
  • Humans
  • Japan
  • Male
  • Middle Aged
  • Reference Values

Substances

  • Apolipoprotein E4
  • Apolipoproteins E